Clinical Course of COVID-19 in Patients with Inflammatory Bowel Disease in Korea: a KASID Multicenter Study

Jin Wook Lee, Eun Mi Song, Sung Ae Jung, Sung Hoon Jung, Kwang Woo Kim, Seong Joon Koh, Hyun Jung Lee, Seung Wook Hong, Jin Hwa Park, Sung Wook Hwang, Dong Hoon Yang, Byong Duk Ye, Jeong Sik Byeon, Seung Jae Myung, Suk Kyun Yang, Sang Hyoung Park

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

In 2020, the novel coronavirus disease 2019 (COVID-19) began to spread worldwide and remains an ongoing medical challenge. This case series reports on the clinical features and characteristics of patients with inflammatory bowel disease (IBD) and confirmed COVID-19 infection. From February 2020 to March 2021, nine patients with IBD had confirmed COVID-19 across four hospitals in Korea. The median age at COVID-19 diagnosis was 42 years. Six patients were male, and seven patients had ulcerative colitis (UC). No patients required oxygen therapy, intensive care unit hospitalizations, or died. The most common symptom was fever, and gastrointestinal (GI) symptoms developed as diarrhea in five patients with UC. Oral steroids were used to combat UC aggravation in two patients. In this case series of nine IBD patients diagnosed with COVID-19 in Korea, the clinical presentation was predominately a mild respiratory tract infection. Most patients with UC developed new GI symptoms including diarrhea

Original languageEnglish
Article numbere336
JournalJournal of Korean Medical Science
Volume36
Issue number48
DOIs
StatePublished - Dec 2021

Keywords

  • Covid 19
  • Crohns disease
  • Inflammatory bowel disease
  • Ulcerative colitis

Fingerprint

Dive into the research topics of 'Clinical Course of COVID-19 in Patients with Inflammatory Bowel Disease in Korea: a KASID Multicenter Study'. Together they form a unique fingerprint.

Cite this